• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

用于肝细胞癌、胆管癌及肝转移性结直肠癌的消融技术。

Ablative technologies for hepatocellular, cholangiocarcinoma, and metastatic colorectal cancer of the liver.

作者信息

Hansen Paul D, Cassera Maria A, Wolf Ronald F

机构信息

Hepatobiliary and Pancreatic Surgery Program, Providence Cancer Center, Providence Portland Medical Center, 4805 NE Glisan St, Suite 6N60, Portland, OR 97213, USA.

Hepatobiliary and Pancreatic Surgery Program, Providence Cancer Center, Providence Portland Medical Center, 4805 NE Glisan St, Suite 6N60, Portland, OR 97213, USA.

出版信息

Surg Oncol Clin N Am. 2015 Jan;24(1):97-119. doi: 10.1016/j.soc.2014.09.003. Epub 2014 Nov 8.

DOI:10.1016/j.soc.2014.09.003
PMID:25444471
Abstract

A wide array of ablation technologies, in addition to the progressive sophistication of imaging technologies and percutaneous, laparoscopic, and open surgical techniques, have allowed us to expand treatment options for patients with liver tumors. In this article, technical considerations of chemical and thermal ablations and their application in hepatic oncology are reviewed.

摘要

除了成像技术以及经皮、腹腔镜和开放手术技术的不断完善外，各种各样的消融技术使我们能够为肝肿瘤患者扩大治疗选择。本文回顾了化学消融和热消融的技术要点及其在肝脏肿瘤学中的应用。

相似文献

1
Ablative technologies for hepatocellular, cholangiocarcinoma, and metastatic colorectal cancer of the liver.用于肝细胞癌、胆管癌及肝转移性结直肠癌的消融技术。
Surg Oncol Clin N Am. 2015 Jan;24(1):97-119. doi: 10.1016/j.soc.2014.09.003. Epub 2014 Nov 8.
2
[Liver resection (part I) -- anatomical basis, indication, and preoperative planning].肝切除术（第一部分）——解剖学基础、适应证及术前规划
Zentralbl Chir. 2006 Apr;131(2):W22-33; W34-5. doi: 10.1055/s-2006-921565.
3
Imaging approach to hepatocellular carcinoma, cholangiocarcinoma, and metastatic colorectal cancer.肝细胞癌、胆管癌和转移性结直肠癌的影像学检查方法
Surg Oncol Clin N Am. 2015 Jan;24(1):19-40. doi: 10.1016/j.soc.2014.09.002. Epub 2014 Oct 11.
4
Management and extent of resection for intrahepatic cholangiocarcinoma.肝内胆管癌的手术管理及切除范围
Surg Oncol Clin N Am. 2009 Apr;18(2):289-305, viii-ix. doi: 10.1016/j.soc.2008.12.010.
5
Primary intrahepatic small-cell carcinoma arising from combined hepatocellular and cholangiocarcinomas.源于肝细胞癌和胆管癌合并的原发性肝内小细胞癌。
J Clin Oncol. 2011 Jul 20;29(21):e630-3. doi: 10.1200/JCO.2011.35.2757. Epub 2011 May 23.
6
Transplantation for cholangiocarcinoma.胆管癌的移植治疗。
Clin Liver Dis. 2011 Nov;15(4):699-715. doi: 10.1016/j.cld.2011.08.004.
7
A case of mucinous cholangiocarcinoma showing features of hepatocellular carcinoma.一例表现出肝细胞癌特征的黏液性胆管癌。
Pathol Int. 2013 Aug;63(8):419-21. doi: 10.1111/pin.12081.
8
Hepatocellular cancer, cholangiocarcinoma, and metastatic tumors of the liver.肝细胞癌、胆管癌和肝脏转移瘤。
Surg Oncol Clin N Am. 2015 Jan;24(1):xiii-xiv. doi: 10.1016/j.soc.2014.10.001. Epub 2014 Nov 8.
9
Hepatocellular cancer, cholangiocarcinoma, and metastatic tumors of the liver.肝细胞癌、胆管癌和肝脏转移瘤。
Surg Oncol Clin N Am. 2015 Jan;24(1):xi-xii. doi: 10.1016/j.soc.2014.10.002. Epub 2014 Nov 8.
10
Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma.肝细胞癌合并胆管癌患者的外科治疗及预后
Ann Surg Oncol. 2009 Mar;16(3):623-9. doi: 10.1245/s10434-008-0278-3. Epub 2009 Jan 6.

引用本文的文献

1
Percutaneous microwave ablation for early-stage intrahepatic cholangiocarcinoma: A single-institutional cohort.经皮微波消融治疗早期肝内胆管癌：单机构队列研究
J Clin Imaging Sci. 2024 Feb 13;14:4. doi: 10.25259/JCIS_59_2023. eCollection 2024.
2
The Diagnostic Value of Contrast-Enhanced Ultrasound and Enhanced CT Combined with Tumor Markers AFP and CA199 in Liver Cancer.肝癌中联合应用增强超声与增强 CT 及肿瘤标志物 AFP 和 CA199 的诊断价值。
J Healthc Eng. 2022 Feb 21;2022:5074571. doi: 10.1155/2022/5074571. eCollection 2022.
3
Radiofrequency ablation in the management of primary hepatic and biliary tumors.
原发性肝脏和胆道肿瘤治疗中的射频消融术。
World J Gastrointest Oncol. 2022 Jan 15;14(1):203-215. doi: 10.4251/wjgo.v14.i1.203.
4
Ablative therapies for hepatic and biliary tumors: endohepatology coming of age.肝脏和胆管肿瘤的消融治疗：肝脏内科学走向成熟。
Transl Gastroenterol Hepatol. 2020 Apr 5;5:15. doi: 10.21037/tgh.2019.10.17. eCollection 2020.
5
Optimized Echo Decorrelation Imaging Feedback for Bulk Ultrasound Ablation Control.优化的回波去相关成像反馈用于体超声消融控制。
IEEE Trans Ultrason Ferroelectr Freq Control. 2018 Oct;65(10):1743-1755. doi: 10.1109/TUFFC.2018.2847599. Epub 2018 Jun 14.
6
Does primary tumor location impact the prognosis of colorectal liver metastases patients after microwave ablation? - Lessons from 10 years' experience.原发性肿瘤位置是否会影响结直肠癌肝转移患者微波消融后的预后？——来自十年经验的教训。
Oncotarget. 2017 Jun 28;8(59):100791-100800. doi: 10.18632/oncotarget.18764. eCollection 2017 Nov 21.
7
Real-Time Spatiotemporal Control of High-Intensity Focused Ultrasound Thermal Ablation Using Echo Decorrelation Imaging in ex Vivo Bovine Liver.在离体牛肝中使用回波去相关成像对高强度聚焦超声热消融进行实时时空控制。
Ultrasound Med Biol. 2018 Jan;44(1):199-213. doi: 10.1016/j.ultrasmedbio.2017.09.007. Epub 2017 Oct 23.
8
[Prognostic biomarkers for metastatic colorectal cancer].[转移性结直肠癌的预后生物标志物]
Pathologe. 2016 Nov;37(Suppl 2):180-185. doi: 10.1007/s00292-016-0204-6.